Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Paper of the Day: Nationwide, retrospective analysis in Austria of real-world outcomes w/ ide-cel & cilta-cel finds trend towards improved PFS w/ cilta-cel; true EMD & prior bispecific therapy before T-cell apheresis assoc. w/ inferior PFS.”
Title: Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria
Authors: Irene Strassl, Alexander Nikoloudis, Lina Zoe Ruesing, Thomas Melchardt, Michael Leisch, Eduard Schulz, Annkristin Heine, Peter Neumeister, Normann Steiner, Dominik Wolf, Wolfgang Willenbacher, Petra Pichler-Izmir, Theresa Lentner, Johannes Clausen, Veronika Buxhofer-Ausch, Sigrid Machherndl-Spandl, Olga Saini, Dagmar Wipplinger, Holger Rumpold, Nina Worel, Werner Rabitsch, Axel Schulenburg, Hermine Agis, Maria-Theresa Krauth.
You can read the full article on WILEY Online Library.
You can find other articles featuring Robert Orlowski on OncoDaily.
